BOSTON, MA -- (MARKET WIRE) -- October 18, 2006 -- Averion International Corp. (OTCBB: AVRO), a clinical research organization (CRO) specializing in oncology, nephrology, dermatology and medical devices, announced today the appointment of Donald Schelling, to Program Director, Dermatology. In this position, Mr. Schelling will oversee Averion clinical dermatology programs and the expansion of Averion's expertise in the therapeutic category. Donald joins Averion from Stiefel Research where he oversaw global clinical research activities and monitoring programs in dermatology.
